SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (948)	12/28/1998 10:16:00 PM
From: ubrx	Read Replies (1) of 1477

Miljenko, To the best of my knowledge the complete reasons for the suspension of the Fiblast N.A. stroke trials have never been fully explained. As you know, the European Stroke trials continue. I would appreciate it if you post any information you come across. I agree that the indications of PVD (peripherial vascular disease) and CAD (coronary artery disease) still hold much potential for Fiblast and VEGF121. Hopefully clinical trials will begin with the next few months. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next